# How Much Weight Can You Lose on Zepbound in 3 Months? | Buy This GLP

A 12-week tirzepatide study averaged 7.3% weight loss. See who was studied and what the longer SURMOUNT-1 trial found after a slow start.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months
Updated: 2026-11-15
Published: 2026-09-18

[← Research](https://buythisglp.com/research)

Evidence

# How Much Weight Can You Lose on Zepbound in 3 Months?

A study of 115 adults found an average weight loss of 7.3% at 12 weeks on tirzepatide. Here is how that result compares with the longer trial.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

TIRZEPATIDE AT 12 WEEKS · 7.3% · Average weight loss in one study · 115 adults with obesity and no diabetes

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   A study of 115 adults with obesity and no diabetes found an average 7.3% weight loss at 12 weeks.
-   In a separate trial analysis, many people who lost less than 5% at week 12 went on to reach that threshold.
-   The published 72-week weight-loss averages answer a different question from what happens in the first three months.

Adults in one observational study lost 7.3% of their starting weight on average at 12 weeks [\[1\]](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months#ref-1). The timing of [early changes on a GLP-1](https://buythisglp.com/research/how-long-does-it-take-for-a-glp1-to-work) varies with the person and the outcome measured. The study included 115 adults with obesity and no diabetes who took tirzepatide, the active ingredient in Zepbound. Its average does not give an individual three-month target.

## What two observational studies found

The 115 adults lost an average of 8.2 kg, or about 18 pounds [\[1\]](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months#ref-1). The study capped the dose at 5 mg. A second report from the same research group found 8.18% average loss in 51 adults over 12 weeks [\[3\]](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months#ref-3). The reports do not establish whether the groups overlapped.

## What happened after a slow start in SURMOUNT-1

A secondary analysis included 1,545 tirzepatide trial participants [\[2\]](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months#ref-2). They took at least 75% of assigned doses and had weight measurements at the required visits. By week 12, 1,267 of them, or 82%, had lost at least 5% of starting weight. Of the 278 who had yet to reach 5%, 250 reached it by week 72.

The analysis excluded people who did not meet the dosing and measurement criteria. Its results apply to the selected trial group. Decisions about continuing treatment depend on your response, the dose you tolerate and your prescriber’s assessment.

## Why the 72-week results are larger

In the full trial, average weight reductions at week 72 were 15.0%, 19.5% and 20.9% [\[4\]](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months#ref-4). Those averages came from the 5 mg, 10 mg and 15 mg groups, respectively. The placebo group lost 3.1% on average. The Zepbound label spaces dose increases and lists 5 mg as one maintenance option for weight management [\[5\]](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months#ref-5). Prescribers consider response and tolerability when selecting a maintenance dose.

## How tirzepatide compared with semaglutide

A US study of routine care compared the formulations labeled for type 2 diabetes [\[6\]](https://buythisglp.com/research/how-much-weight-can-you-lose-on-zepbound-in-3-months#ref-6). The doses covered in [a separate three-month comparison](https://buythisglp.com/research/tirzepatide-vs-semaglutide-mismatched-doses) illustrate how the regimens can differ. In the US study, the on-treatment weight decrease at three months was 2.4 percentage points greater with tirzepatide. Discontinuation ended follow-up for over half of each treatment group.

## Frequently asked

How much weight can you lose on Zepbound in 3 months?

In a study of 115 adults with obesity and no diabetes, average weight loss at 12 weeks was 7.3%, or about 18 pounds. Your result may differ.

Can weight loss continue after the first three months?

Yes. Among 278 participants in a selected trial analysis who lost less than 5% by week 12, 250 reached that threshold by week 72.

Does the 20.9% trial result describe the first three months?

The 20.9% average was measured at week 72 in the 15 mg group. The early studies describe different groups and follow-up periods.

## Sources

1.  \[1\] Angelopoulos N, Androulakis I, Rizoulis A, Boniakos A, et al. (2026). A real-world study of tirzepatide for weight loss in adults without diabetes mellitus International Journal of Obesity. [PMID 41354867](https://pubmed.ncbi.nlm.nih.gov/41354867/)
2.  \[2\] Ard J, Lee CJ, Gudzune K, Addison B, et al. (2025). Weight reduction over time in tirzepatide-treated participants by early weight loss response: Post hoc analysis in SURMOUNT-1 Diabetes, Obesity and Metabolism. [PMID 40677091](https://pubmed.ncbi.nlm.nih.gov/40677091/)
3.  \[3\] Angelopoulos N, Rizoulis A, Boniakos A, Fousteris E, et al. (2026). Early changes in body composition with tirzepatide in adults with obesity: a real-world BIA study Nutrition. [PMID 42275945](https://pubmed.ncbi.nlm.nih.gov/42275945/)
4.  \[4\] Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity The New England Journal of Medicine. [PMID 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)
5.  \[5\] Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection: Prescribing Information, section 2.1, Recommended Dose Escalation Schedule DailyMed, U.S. National Library of Medicine. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
6.  \[6\] Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, Brar R, et al. (2024). Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity JAMA Internal Medicine. [PMID 38976257](https://pubmed.ncbi.nlm.nih.gov/38976257/)

## Where to get it

### The cheapest GLP-1

Every seller that publishes a price, ordered lowest first on the standing month-to-month rate, plus the question to ask before you pay any of them.

[See the board →](https://buythisglp.com/best/cheapest-glp1)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
